Gastric bypass surgery is performed on people who have morbid obesity, type 2 diabetes, high blood pressure, or other weight-related health problems.
Is it true that gastric bypass surgery is performed on people who have morbid obesity, type 2 diabetes, high blood pressure, or other weight-related health problems?
Yes. Gastric bypass and other bariatric procedures are established surgical interventions specifically indicated for patients suffering from severe obesity, type 2 diabetes, high blood pressure, and related metabolic complications.
Verdict: SUPPORTED · 8 sources for, 0 against · Last checked
All retrieved studies consistently confirm that bariatric and metabolic surgeries (such as Roux-en-Y gastric bypass) are performed on individuals with severe or morbid obesity, frequently addressing weight-related conditions like type 2 diabetes and hypertension. There is no evidence refuting this standard clinical indication.
Get citation
Wiebe, N. & Tonelli, M. (2023). Long-term clinical outcomes of bariatric surgery in adults with severe obesity: A population-based retrospective cohort study. doi.org. https://doi.org/10.1101/2023.05.31.23290770
See more details
Get citation
YY, X., D, H., & Y, J. (2026). Long-Term Effects of Bariatric Surgery on Type 2 Diabetes: Mechanisms, Outcomes, and Clinical Implications: A Focused Review.. doi.org. https://doi.org/10.3791/74093
Get citation
I, T. & Y, G. (2026). Comparison of 5-year glycemic outcomes after sleeve gastrectomy and Roux-en-Y gastric bypass in patients with pre-operative dysglycemia.. doi.org. https://doi.org/10.14744/nci.2026.26235
Get citation
L, H., F, G., A, C., A, V., M, M., S, R., C, L., L, S., A, G. R. d. G., M, L. V., M, P., C, M., N, S., L, M., M, C., S, F., J, V., & N, V. (2026). Diabetes remission 10 years after bariatric surgery: Extension study of a randomized controlled trial.. doi.org. https://doi.org/10.1016/j.clnu.2026.106795
Get citation
J, C., W, L., Y, B., & C, J. (2026). Contemporary perspectives on metabolic surgery for type 2 diabetes: surgical techniques, outcomes, and complications.. doi.org. https://doi.org/10.3389/fendo.2026.1849157
Get citation
AA, S., MA, S., AE, T., A, A., A, M., A, E., M, Y., AS, A., & A, Y. (2026). Effect of Roux-En-Y Gastric Bypass on Albuminuria in Morbidly Obese Patients with Type-2 Diabetes Mellitus: A Prospective Non-Randomized Controlled Study with 15-Month Follow-Up.. doi.org. https://doi.org/10.2147/ijgm.s620065
Get citation
O, T., A, M., N, J., G, R., & I, L. (2026). Laparoscopic One Anastomosis Gastric Bypass (OAGB) for Type 2 Diabetes Mellitus: A 10-Year Single-Center Experience with 127 Patients.. doi.org. https://doi.org/10.1007/s11695-026-08646-w
Get citation
DW, K. & S, C. (2026). Changes in 24-Hour Ambulatory Blood Pressure After Bariatric and Metabolic Surgery in Patients With Morbid Obesity: A Retrospective Cohort Study.. doi.org. https://doi.org/10.17476/jmbs.2026.15.2.121
What does the evidence say?
All retrieved studies consistently confirm that bariatric and metabolic surgeries (such as Roux-en-Y gastric bypass) are performed on individuals with severe or morbid obesity, frequently addressing weight-related conditions like type 2 diabetes and hypertension. There is no evidence refuting this standard clinical indication.
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work